Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Excelsior Medical CoTPE:4104 +0.28%85 EV-to-EBIT is 11.30 as of Sep. 01, 2026, which is 22% above its 10-year median of 9.30. GuruFocus rates TPE:4104 with a GF Score™ of 85/100 and a GF Value™ of NT$86.36 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 97 Medical Distribution companies, Excelsior Medical Co ranks worse than 50.52% on this metric.
Excelsior Medical Co (TPE:4104) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Excelsior Medical Co's Enterprise Value for the quarter that ended in Jun. 2026 was NT$14,218 Mil.
Excelsior Medical Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1,300 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Excelsior Medical Co EV-to-EBIT Related Terms
Excelsior Medical Co EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Excelsior Medical Co's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Excelsior Medical Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Excelsior Medical Co EV-to-EBIT vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Excelsior Medical Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Excelsior Medical Co's EV-to-EBIT falls into.
Excelsior Medical Co's current Enterprise Value is NT$14,689 Mil.
Excelsior Medical Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1,300 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Excelsior Medical Co (TPE:4104) has a EV-to-EBIT of 11.30 as of Sep. 01, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Excelsior Medical Co and its competitors. This is 22% above median its historical median of 9.30. Over the past decade, Excelsior Medical Co's EV-to-EBIT has ranged from 6.32 to 13.75. According to the industry distribution chart, Excelsior Medical Co ranks #49 out of 97 companies in the Medical Distribution industry, placing it in the top 50.5%.
Is Excelsior Medical Co's EV-to-EBIT too high?
Excelsior Medical Co's current EV-to-EBIT of 11.30 is 22% above median its 10-year median of 9.30. Over the past 10 years, this metric has ranged from a low of 6.32 to a high of 13.75. The Medical Distribution industry median EV-to-EBIT is 11.30. Excelsior Medical Co's value of 11.30 is 0% at this industry median. Based on the distribution chart, Excelsior Medical Co ranks #49 out of 97 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Excelsior Medical Co has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Excelsior Medical Co's EV-to-EBIT compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Excelsior Medical Co ranks #49 out of 97 companies for EV-to-EBIT. This places Excelsior Medical Co in the lower half of its industry. The industry median EV-to-EBIT is 11.30. Excelsior Medical Co's value of 11.30 is 0% at this benchmark. Historically, Excelsior Medical Co's own EV-to-EBIT has ranged from 6.32 to 13.75 over the past decade. While the company's 10-year median is 9.30 vs. the industry median of 11.30, Excelsior Medical Co has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Distribution company?
The median EV-to-EBIT among Medical Distribution companies is 11.30, based on 97 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Excelsior Medical Co's current EV-to-EBIT of 11.30 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Excelsior Medical Co and its competitors. For the Medical Distribution industry, the median EV-to-EBIT is 11.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Excelsior Medical Co's current EV-to-EBIT is 11.30, which is 22% above median its own 10-year median of 9.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Excelsior Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Excelsior Medical Co (TPE:4104) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$86.36, compared to a current price of NT$71.20 — trading 17.6% below its estimated fair value. The current EV-to-EBIT is 11.30, which is 22% above median its 10-year median of 9.30 and 0% at the Medical Distribution industry median of 11.30. Excelsior Medical Co's overall GF Score™ is 85/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Excelsior Medical Co (TPE:4104), the current EV-to-EBIT is 11.30 as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Excelsior Medical Co (TPE:4104) Overvalued in 2026?
Based on GuruFocus' analysis, Excelsior Medical Co stock appears to be undervalued.
The current stock price of NT$71.20 is trading 17.6% below its estimated GF Value™ of NT$86.36.
GuruFocus considers Excelsior Medical Co to be Modestly Undervalued.
Key valuation signals for TPE:4104:
EV-to-EBIT: 11.30 (22% above median its 10-year median of 9.30)
GF Value™: NT$86.36 vs. price of NT$71.20 (17.6% below fair value)
Industry Position: 0% at the Medical Distribution median (#49 of 97)
No single metric tells the full story. See the TPE:4104 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Excelsior Medical Co Ltd is engaged in the sale of medical supplies and medicines, home medical devices, and medical equipment with brand names of local and foreign manufacturers. Its product offerings include Fasflo hollow fiber dialyzer, Renabio sodium chloride injection, acid concentrates, Sunder blood purification tubing set, JMS blood bags, etc. The Group's reportable segments include Excelsior, Dynamic, Arich, and Others. Maximum revenue is generated from the Excelsior segment. Geographically, it derives key revenue from Taiwan and also has a presence in Hong Kong, China, the Philippines, Malaysia, and Indonesia.
85GF Score
Get the complete analysis for TPE:4104
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4104 has been successfully added to your 
